Surgalign Inc.

0.18
-0.00 (-1.59%)
At close: Nov 14, 2024, 9:00 PM

Company Description

Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide.

It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine.

The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability.

In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery.

The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force.

The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.

Surgalign Inc.
Surgalign  Inc. logo
Country United States
IPO Date Aug 11, 2000
Industry Medical - Devices
Sector Healthcare
Employees 217
CEO Terry M. Rich

Contact Details

Address:
520 Lake Cook Road
Deerfield, Illinois
United States
Website https://www.surgalign.com

Stock Details

Ticker Symbol SRGA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001760173
CUSIP Number 86882C204
ISIN Number US86882C2044
Employer ID 83-2540607
SIC Code 3842

Key Executives

Name Position
Terry M. Rich Pres, Chief Executive Officer & Director
Bob Watkins Chief Technology Officer
David B. Lyle Chief Financial Officer
Paolo G. Amoruso Chief Legal Officer, Gen. Counsel & Corporation Sec.
Suzanne C. Zoumaras Chief People Officer
Bryan Cornwall Executive Vice President of Research and Clinical Affairs
Christopher Thunander Vice President & Chief Accounting Officer
Dr. G. Bryan Cornwall P.Eng., Ph.D. Executive Vice President of Research and Clinical Affairs
Enrico Sangiorgio Executive Vice President of International
John N. Varela Executive Vice President of Global Operations
Marc MacKey Executive Vice President of Digital Surgery
Olivier M. Visa Pres of Global OEM
William Scott Durall Chief Commercial Officer

Latest SEC Filings

Date Type Title
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 13, 2023 15-12G Filing
Oct 02, 2023 S-8 POS Filing
Oct 02, 2023 S-8 POS Filing
Oct 02, 2023 S-8 POS Filing
Oct 02, 2023 POS AM Filing
Oct 02, 2023 POS AM Filing
Oct 02, 2023 POS AM Filing
Sep 29, 2023 8-K Current Report
Sep 18, 2023 4 Filing